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Mediation analysis is a useful research method that potentially
allows identiﬁcation of the mechanisms through which treatments
affect patient outcomes. This chapter reviews the theoretical
framework, research designs and statistical approaches used in
mediation analysis. It describes what can be learnt from previous
mediation research, much of which has investigated mediating
factors of psychosocial interventions in other health conditions. It
also summarises the few treatment-mediation studies of psycho-
social interventions conducted in back pain.
This chapter shows that there is emerging evidence about the role
of some psychological factors as potential treatment mediators,
such as self-efﬁcacy and catastrophising. Mediation analysis can
equally be applied to non-psychological factors. Pre-planned and
appropriately conducted mediation analysis in adequately pow-
ered clinical trials would be a step forward in understanding
treatment effects in back pain and improving patient management.
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A recurring conclusion of high-quality systematic reviews and randomised controlled trials (RCTs)
in the ﬁeld of back pain is that most treatments show modest effects compared to natural course and
small or no differences between the effectiveness of different interventions [1–4]. This leads to
equivocal and sometimes contradictory messages in clinical practice guidelines [5,6] and frustration in
clinicians attempting to provide evidence-based care for their patients. In part, the underwhelming
results reported by these studies are likely due to incomplete understanding of what factors might be
necessary to be included in interventions to help inﬂuence outcome. Studies have examined the
physical [7,8], psychological [9,10] and social [11,12] aspects of interventions to try to identify these
factors. To date however, satisfying answers remain elusive.
Mediation analysis offers a method of testing theories regarding the causal links between a pre-
dictor and an outcome. The establishment of causal mechanisms as opposed to simply associative links
is critical to the understanding of the processes of treatment effect. Mediation analysis can be applied
to data from various types of study designs: cross-sectional surveys, clinical registries, longitudinal
cohorts and randomised and non-randomised clinical trials. While different study designs impose
different restrictions on the explanatory power of mediation analysis, this ﬂexibility makes mediation
analysis a useful supplement to other, more commonly used, methods of analysis.
Mediationanalysistestswhethertheinﬂuenceofapredictorortreatmentonanoutcomeoccursviachange
in a particular intermediate variable, themediator. For example, a treatment could aim to inﬂuence fear-
avoidant behaviours, which if successfully changed could be responsible for change in outcomes such as
disabilityorpainintensity.Wherethepredictorvariableisa‘clinicalfeature’associatedwithacondition,such
aspainintensityorpsychologicaldistress,mediationanalysishelpsusunderstandthepathwaybetweenit
andtheoutcomeofinterest.Thisinformationcanbeveryusefulinidentifyingfactorsthatshouldbetargetedin
treatment.Wherethepredictorisa‘speciﬁctreatment’,suchasallocationtoaparticulartreatmentarminan
RCT,mediationanalysisprovidesinsightintowhethertheeffectivenessor ineffectivenessofatreatmentis
consistentwiththeoriesregardingitsmechanism.
Currently in the management of back pain, many interventions are based on imprecise theoretical
rationales, rather than empirically derived hypotheses. It is potentially very useful to disentangle
factors merely associated with outcome from those that could potentially help to explain treatment
effects. Making distinctions between causes, consequences and epiphenomena is vital, as treatments
that target factors that are not modiﬁable or inﬂuential are unlikely to be successful. For example,
anxiety has been shown to be predictive of poor recovery from low back pain (LBP) [13] and is
commonly associated with pain. However, a recent mediation study [14] showed that the relationship
between pain and disability in patients with LBP is not mediated by anxiety. This suggests that a
treatment designed to only target anxiety in LBP patients would be unlikely to have an important effect
on pain-related disability.
Identifying the mechanism of action of a particular treatment offers the opportunity to optimise its
effectiveness. Investigation of the relationship between an intervention and its effect via mediation
analysis can provide information as to whether and to what extent the hypothesised action is real. This
information can be used to modify the intervention in order to target the appropriate mediating factor
more directly and enhance the capacity of the treatment to reach its full potential effect.
To date, relatively few mediation analyses have been conducted in back pain research despite such
studies being potentially capable of providing important insight into questions relevant to the ﬁeld. The
aim of this article is to introduce the theory and practice of mediation analysis and discuss some of the
issues involved with study design, conduct and interpretation.
What is a mediator?
It is important to deﬁnewhat wemean by the term ‘mediator’ along with some other, related terms,
as these terms can have slightly different meanings in different ﬁelds [15,16] and this can be a source of
confusion.
Mediators, also known as intermediate variables [17] or indirect effects [18], are variables that help
explain how a treatment might work [15,19] and are by deﬁnition on the pathway between predictor
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the direct effect and indirect (mediated) effect. Mediated effects differ from the direct effect of treat-
ment in that the mediated effect combines the paths from the treatment to the mediator and from the
mediator to the outcome. Mediators are modiﬁable and change during the course of, or in response to,
treatment. For example, Fig. 1 shows that an intervention designed to reduce disability in back pain
patients may work by reducing their levels of fear avoidance. The intervention causes fear avoidance to
reduce, which results in improved function.
It is important to note the distinction between a mediator and a confounder. Confounders may
explain the relationship between two variables but are not on a supposed causal pathway between
them [20,21]. For example, in an observational study including different treatment options, patients
referred for an exercise programme may be younger whereas those offered pain relief may be older.
Functional outcomemay turn out to be better in those offered the exercise programme. However, age is
not amediator of treatment effect as it cannot be changed by treatment, even though it may be causally
associated with function. In this case, age is a confounder due to the unequal distribution of age be-
tween the two groups.
It is equally important to distinguish between a mediator and a treatment-effect modiﬁer or
moderator variable. A moderator is a baseline characteristic that stratiﬁes treatment effect (i.e.,
identiﬁes for whom a treatment is likely to have the most effect) but is not on a supposed causal
pathway. For example, status on a prediction rule [22] at baseline has been reported to predict outcome
in response to manual therapy. This does not necessarily mean that the features measured by the rule
(e.g., hip range of motion, fear–avoidance beliefs and duration of symptoms) ‘cause’ the person’s
disability or are all addressed by the treatment.
It is important to note that while Fig. 1 denotes a single-mediator model, this is unlikely to be the
case in reality. It is much more likely that several mediators exist on a pathway between the predictor
or treatment and the outcome (e.g., conﬁdence in their clinician or the prescription of pain medication
might help to reduce the patient’s fear avoidance, leading to an improvement in functioning). However,
for simplicity, we only discuss examples of single-mediator models in this chapter.
Mediation across different study designs
Regardless of the way mediation is deﬁned or how it is statistically analysed, it is described using
causal language [17,23]. The concept of causality has a number of facets, but in mediation analysis,
those most commonly discussed are temporality, consistency and dose–response [24]. It should beFig. 1. Treatment mediation.
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association is present, this can never be fully established [25,26].
Temporality is the sequence in which variables change. In order for one variable to be potentially
causing another, it must precede the proposed outcome in time [27]. It has been suggested that
establishing temporality is less complicated in the context of an RCT compared to observational study
designs. This is because an RCT has a clear ‘start’ and ‘end’ point to the intervention and any given
variable that changes during or in response to treatment, and is associated with that treatment, is a
potential mediator [17]. However, in order to truly establish a mediating pathway, we also need to
consider how many assessments are required to establish temporality and when these assessments
should take place. For example, we might expect an intervention to have an effect on patients very
quickly so that we need to assess them early on to pick up any change, or perhaps we expect the
intervention will take some time to have an impact so that we need to carry out assessments over a
longer period of time. Themore assessments that are included, themore conﬁdent we can be about the
order in which variables change [28], although this does require the use of increasingly complex
modelling procedures. It also increases patient burden as theywill have to complete a larger number of
questionnaires, examination procedures and/or biomedical tests.
Consistency is the observation of similar ﬁndings across multiple studies [27]. As with other study
designs, the replication of ﬁndings from mediation studies in different settings and samples increases
conﬁdence in their accuracy. Dose–response is the observation of increasing or decreasing effect on
outcome depending upon the level of (change in) the mediator [24]. These two aspects indicate that
establishing mediating effects in different study designs, in different contexts and in different pop-
ulations provides more convincing evidence for speciﬁc mediating factors.
Most research examining mediation has been performed in cross-sectional studies and therefore is
of limited usefulness because temporal precedence cannot be established [29]. However, ﬁnding an
association between the potential mediator and the outcome might be an important ﬁrst step in
establishing consistency. Studies that include longitudinal analyses are much more useful from a
mediation perspective [30] as they allow the investigation of associations between variables over time,
helping to establish temporality. Longitudinal designs can also provide some information on dose–
response by investigating whether there is an association between the magnitude of change in the
potential mediator and magnitude of change in the outcome. However, neither design allows causal
mechanisms to be established. Clinical trial designs have several advantages over observational study
methods for providing evidence for causality and reducing bias [31–34], such as active manipulation of
the potential mediator, which lends more credence to any mediating effects found in the treatment
arm (yet not in a control arm) and also helps to best establish dose–response. These factors help bring
us closer to our goal in mediation: that of ﬁnding a causal pathway that explains the link between the
predictor (independent) variable (in this case, the intervention) and the outcome (dependent) variable.
In summary, while mediating factors can be explored using a variety of study designs, RCTs have the
potential to provide the most robust answers about how treatments work. However, observational
studies and other research designs may be useful in developing testable and empirically based hy-
potheses about treatment mediation. Identiﬁcation of causal mechanisms is strengthened by the
plausibility of mechanisms based on previous evidence, consistency of ﬁndings with those from pre-
ceding studies and the demonstration of dose–response.
Action Theory and Conceptual Theory
Action Theory and Conceptual Theory provide a framework for understanding and interpreting
mediation analyses in controlled trials. Action Theory refers to whether the intervention potentially
causes signiﬁcant change in the mediator, and Conceptual Theory refers to whether the outcome of
interest is affected by change in the mediator (see Fig. 1) [35]. Action Theory addresses the question of
whether the intervention is actually effective according to its theorised mechanism [36]. Conceptual
Theory provides information regarding whether the rationale upon which the treatment is based is
valid. Chen [37] explains that a weak (or absent) relationship between the intervention and the
mediator would suggest that the intervention is not being implemented in the optimum way (Action
Theory), whereas if the relationship between themediator and outcomewasweak or non-existent, this
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Thus, the relationships (or lack thereof) observed in both parts of the model provide useful and
interpretable information.
Mediation analysis: how is it done?
Review of statistical approaches to mediation analysis
A number of different approaches to conducting mediation analysis have been proposed. MacK-
innon et al. [18] identiﬁed 14 different methods, which they grouped into three different approaches:
causal steps, difference in coefﬁcients and product of coefﬁcients.
1. Causal steps’ approach
These methods seek to test different links in a chain of variables inwhich the order is assumed to be
causal [18,38]. They involve using multiple regression analysis to test each of the paths illustrated in
Fig. 1, and each path must be statistically signiﬁcant. In the context of an RCT, the test of mediation
occurs when the potential mediating factor is included in the model with the independent (treatment)
and dependent (outcome) variables. If the relationship between treatment and outcome is no longer
signiﬁcant or is substantially reduced when the potential mediator is included, a mediation effect is
identiﬁed [15,18]. The contribution of themediating variable to the relationship between the treatment
and outcome is sometimes estimated by the proportional change that occurs in the relationship be-
tween treatment and outcome when the mediator is introduced to the model [39].
However, these approaches are criticised in the literature [18,40,41]. The requirement for the
treatment-outcome path to be statistically signiﬁcant has been contested by a number of authors as it
reduces the approach’s power to detect mediating effects [18] and is highly dependent on sample size;
hence, larger studies are more likely to show signiﬁcant results [17]. Further, only performing mediation
analysis in studieswhere there is a treatment effect precludes research intowhy treatments ‘donot’work.
Overall, the review by MacKinnon et al. [18] of all 14 methods concluded that the causal steps’
approach was the least optimal test of mediation. Although some researchers still advocate their use in
certain contexts (e.g., Ref. [42]), they appear to have been superseded by more sophisticated methods.
2. Difference in coefﬁcients’ approach
This approach examines the difference between regression coefﬁcients before and after the in-
clusion of a potential mediating variable [18]. Conceptually, this is similar to the causal steps’ approach
but the statistical equations used are different (see MacKinnon et al. [18] or Hayes [40] for a detailed
discussion). This approach has been found to have more power but MacKinnon’s review found the
method to be still susceptible to Type II errors (a true mediation effect is missed) and useful only when
testing a single mediating factor. As a single-mediator model is often too simplistic to suitably account
for real-world situations, the usefulness of this approach is limited.
3. Product of coefﬁcients’ approach
This ﬁnal approach involves multiplying the regression coefﬁcients of the proposed mediating
pathways (paths a and b in Fig. 1) to estimate the amount of variance in the outcome that is explained
by the treatment through themediator [18]. Sobel [43] extended this method to allow determination of
its statistical signiﬁcance, by dividing the product of coefﬁcients by its standard error and comparing
that value to a normal distribution.
However, the Sobel test assumes that the mediated effect is normally distributed [18,44], which
often may not be the case. Several methods have been proposed to deal with this, (see Ref. [18]) the
most promising of which is the statistical technique known as bootstrapping [29,44]. Bootstrapping
does not assume normal distribution and allows the generation of bias-corrected conﬁdence intervals
(CIs) around the mediation effect. It can also be applied to smaller samples [45], which helps to
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innon and colleagues argue that this approach should be the preferred method for investigating
mediation effects.
Statistical methods for testing mediation
To perform the analyses described above, linear regression or structural equation modelling (SEM)
techniques are most often used [16]. Linear regression is simple to use and perhaps more familiar to
researchers but makes strong assumptions about the data that are not always satisﬁed. For example,
the assumption of no measurement error in the tools used to assess the variables of interest [15] is
difﬁcult to sustain in the investigation of psychological factors where the variables being examined are
latent and therefore not directly measurable. Measurement error is a particular problem when using
regression analysis for mediation, as we are trying to establish whether change in a particular factor is
responsible for change in the outcome. Measures need to be highly accurate when measuring change,
as this involves at least two measurements, each with its own error [46].
Although more complex, SEM is viewed as a better choice of statistical technique for mediation
analysis. SEM is a combination of regression analysis and factor analysis and, while making many of the
same assumptions about the data, it handles the inclusion of several mediating factors more readily, it
can include latent (unobserved) factors and it can account for measurement error [15,30,44]. SEM also
provides goodness-of-ﬁt statistics that allow comparisons between tested models [31]. This technique
does however require larger sample sizes than traditional regression analysis [47,48].
More recent developments in mediation analysis methods include latent growth modelling (LGM),
performed within SEM [38]. This method allows the inclusion of several time points for the mediator
and the outcome variable and also allows the modelling of the change that occurs within an individual
(within-subject effects) rather than only change between different people (between-subject effects)
[49].
Overall, this literature suggests that a product of coefﬁcients approach performed using SEM, with
bootstrapped CIs, is currently the most effective method for addressing the assumptions made when
performing mediation analysis. However, while these more complex statistical techniques are
necessary in order for us to gauge more accurately the mediating effect of particular variables, the
results may be more difﬁcult to interpret and more difﬁcult to implement in clinical settings. It is
important that the right balance is struck between the integrity of the analysis performed and its
practical application.
What evidence on treatment mediation does already exist?
Evidence from other ﬁelds
To date, research into treatment-mediating factors has mostly been undertaken in ﬁelds other than
musculoskeletal health, particularly in the area of behavioural interventions. The results of this work
have been synthesised in four systematic reviews for the outcomes of physical activity in children and
adults [50], change in dietary behaviour in adolescents [35,51] and the physical and psychological
health of cancer patients [36]. These reviews not only describe the evidence for factors mediating these
outcomes but also report the methodological quality of the included studies and make recommen-
dations on the design of future studies of mediation.
These reviews also report on the design [51] and adaptation [35] of a critical appraisal tool that can
be used to assess aspects of study design, such as the properties of the measures used and whether the
study was adequately powered (see Table 1). This tool was further adapted [50] to extend the appraisal
of mediation methodology by including an assessment of temporality and a judgement of the
appropriateness of the analysis used.
These systematic reviews identiﬁed a variety of potential psychosocial mediators, with self-efﬁcacy
being the one most tested and most often found to mediate outcomes. However, the reviews found
considerable heterogeneity in their included studies (populations, factors investigated, methods and
strength of ﬁndings) that precluded robust conclusions.
Table 1
Summary of the development of the critical appraisal tool.
Lubans et al. [51] Cerin et al. [35] Mansell et al. [this review]
Did the study cite a theoretical
framework?
O O
Were the study measures/
procedures designed to
inﬂuence mediating variables?
O O
Were pilot studies conducted/
reported to test the effect
of the intervention on
mediators?
X O
Was an objective measure
of physical activity used?
X X
Were the psychometric
characteristics of mediator
variables reported and were
they within accepted ranges
(Cronbach’s alpha and test-
retest reliability >.60)?
O O
Did the study report a power
calculation and was the study
adequately powered to detect
mediation?
O O
Did the study use an
experimental design?
O O
Was post-intervention physical
activity controlled for baseline
physical activity?
X X
Were all 3 steps for testing validity of a
theory of behaviour change performed?
X
Were the psychometric characteristics
of the outcome measure reported, and
were they within acceptable ranges
(i.e., test-retest or Cronbach’s alpha>.60?)
O
Were statistically appropriate/
acceptable methods of data analysis used?
O
Did the study ascertain whether
changes in the mediating variables
preceded changes in the outcome
variables?
O
Did the study report a change between
baseline and follow-up for each mediator
tested/reported?
Was the change in the potential mediator
correlated with change in outcome?
Did the study control for possible
confounding factors, e.g., baseline values?
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retical links between the variables of interest, use adequate measures of constructs, establish temporal
precedence, use only appropriate tests of mediation, be adequately powered and report a power
calculation and include more complex models that test multiple mediators reﬂective of the complex
nature of the interventions. They also advocated the calculation of CIs of the mediated effect, which is
possible using the bootstrapping method.
Systematic review of treatment-mediation research in musculoskeletal pain
In order to explore mediation research in the musculoskeletal ﬁeld, a systematic review of medi-
ators of psychological interventions for musculoskeletal pain was conducted by one of the authors
(GM). The aim was to identify mediators of psychological musculoskeletal pain interventions and
report the methodological quality of the studies investigating them.
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etal pain (including back pain) who had received a psychological intervention aimed at reducing their
level of disability. A psychological intervention was deﬁned as any intervention that speciﬁcally aimed
to change psychological factors during treatment. Included studies needed to report results from some
form of mediation analysis, measure functional disability as an outcome, be available in full-text En-
glish and have been peer-reviewed. Although some mediation methods appear superior, any method
was deemed acceptable for inclusion in order to incorporate the maximum number of studies. Studies
were identiﬁed via a detailed search (available from the ﬁrst author) conducted in four electronic
databases (PsycINFO from 1806, MEDLINE from 1950, AMED from 1985 and CINAHL from 1981) from
their inception up until February 2012.
The critical appraisal tool used in the previous reviews was further adapted to our topic of interest
and some new items, recommended in the above review of the methodological literature, were added.
Table 1 describes the tool. Total score was not calculated, as current recommendations suggest that
descriptive summaries of the various quality criteria are more interpretable and reliable than the use of
quality sum scores [52].
The electronic search identiﬁed 7325 unique references. After scanning titles and abstracts, 93 full-
text articles were retrieved for further inspection and seven papers were ﬁnally included. The main
reasons for exclusion were: no mediation analysis performed, disability not measured as a study
outcome, not a musculoskeletal pain population, not an intervention study and no control or com-
parison group. Similar to previous reviews, there was heterogeneity in the study populations, the
method of mediation analysis performed and the intervention investigated. The seven included studies
are summarised in Table 2.Included studies
Four studies [53–56] were conducted in the USA, two in The Netherlands [57,58] and one in Sweden
[59]. Two studies were conducted in primary care [57,58], one in secondary care [54] and the rest
examined community populations or speciﬁc patient groups (e.g., Wicksell et al. [59] recruited patients
through a patient organisation for sufferers of their condition of interest). A range of painful muscu-
loskeletal conditions were investigated including ﬁbromyalgia [53], whiplash associated disorder [59],
temporomandibular disorder [54], knee or hip osteoarthritis [55,56] and LBP [57,58]. Sample sizes
ranged from 21 [59] to 351 [56]. Several studies included more than one active intervention group
[55,57,58], and all the interventions lasted for either 8 or 10weeks, except in the case of Focht et al. [55],
where the intervention lasted for 18 months. The length of follow-up varied between 4 [59], 6
[53,54,56] and 12months [58], and two studies did not follow up patients up after the intervention had
ended.Mediators identiﬁed
Numerous different psychological mediators were tested in the included studies and a small
number were found to mediate the outcome of the intervention (see Table 2). Reduced pain cata-
strophising [54,57,58] and increased self-efﬁcacy [54–56] were the factors most often tested as me-
diators and pain catastrophising was found to mediate outcome in every study that tested it. Other
factors that were found to mediate outcome in single studies were pain coping [54], reduced psy-
chological inﬂexibility [59] and a reduction in negative pain beliefs [54].
Two studies focussed speciﬁcally on mediators of psychological interventions in chronic LBP.
Smeets et al. [57] investigated the mediating effects of change in internal control and pain cata-
strophising. They found that only pain catastrophising mediated the outcome of disability for both
cognitive–behavioural treatment and also active physical treatment, suggesting that treatment ele-
ments that do not deliberately target cognitive factors can still reduce pain catastrophising. Spinhoven
et al. [58] examined whether changes in pain coping and cognition mediated the outcome of activity
tolerance following cognitive–behavioural treatment. They found that changes in catastrophising
partially mediated this particular outcome.
Table 2
Summary of papers included in the systematic review.
Reference Study population, setting Intervention(s) and control Follow-up Factors found to mediate
functional disability
Focht et al.,
2005 [55]
Patients with
radiographic
evidence of knee
OA
Community
Exercise (n ¼ 80)
Dietary weight loss
(n ¼ 82)
Combination therapy
(n ¼ 76)
Control: Healthy
lifestyle (n ¼ 78)
6 m, 18 m Stair climbing self-
efﬁcacy
Nicassio et al.,
1997 [53]
Patients with diagnosed
ﬁbromyalgia
Community
Behavioural treatment
(n ¼ 48)
Control: Education
(n ¼ 38)
Post-treatment
(10weeks); 6 m
None
Seymour et al.,
2009 [56]
Patients with hip/Knee OA
Community
Fit & Strong! Programme
(exercise therapy)
delivered by
physiotherapists
Control: Fit and Strong!
Programme delivered by
certiﬁed exercise instructors
2 m, 6 m Exercise adherence
self-efﬁcacy
Smeets et al.,
2006 [57]
Participants with chronic
non-speciﬁc low back pain
Primary care
Cognitive–behavioural
therapy (n ¼ 55)
Active Physical Therapy
(n ¼ 52)
Combined Therapy
(n ¼ 55)
Control: Waiting list
(n ¼ 49)
Post-treatment
(10 weeks)
Pain catastrophising
Spinhoven et al.,
2004 [58]
Patients with chronic low
back pain
Primary care
Operant Behavioural
Treatment with Cognitive
Coping Skills (n ¼ 59)
Operant Behavioural
Treatment with Group
Discussion (n ¼ 58)
Control: Waiting list
(n ¼ 31)
12 m Catastrophising
Turner et al.,
2007 [54]
Patients with diagnosed
temporomandibular disorder
(TMD)
Secondary care
Cognitive–behavioural
therapy (n ¼ 55)
Control: Education/
attention (n ¼ 60)
Post-treatment
(8 weeks), 6 m,
12 m
Pain beliefs, coping,
catastrophising and
self-efﬁcacy
Wicksell et al.,
2010 [59]
Patients diagnosed with
whiplash-associated disorder
(WAD)
Community – WAD support
group
Acceptance and Commitment
Therapy (n ¼ 11)
Control: Treatment as usual
(n ¼ 10)
Post-treatment
(8 weeks), 4 m
Psychological ﬂexibility
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number of studies featuring these analyses to date and by the methodological issues reported below.
Methodological issues
The critical appraisal of the seven mediation studies highlighted issues similar to those described in
the reviews of other health conditions. Most of the interventions were based on aspects of cognitive–
behavioural theory, but the techniques used to treat patients varied widely. For example, the trials of
both Smeets et al. [57] and Spinhoven et al. [58] trials in back pain used operant behavioural tech-
niques; but, while one of them [57] focussed on aspects of graded activity and problem solving, the
other [58] only reported trying to increase ‘healthy’ behaviours without giving speciﬁc details as to
how this was done. The variety of techniques and principles employed in the included studies, and the
different variables investigated as potential mediators, highlights the potential difﬁculties in using
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theory might work in an intervention context.
Closely related to theory is the choice of potential mediator variables. Just as theory might help
in guiding how to perform an intervention, it might also help in choosing variables that are likely
to change during treatment and how they are likely to be associated with outcome [60]. Where
empirical evidence is not available, it is helpful to test these associations, which are prerequisites
for mediation, through preliminary analysis before conducting mediation analysis. The presenta-
tion of results from preliminary analysis was included in the critical appraisal tool. All of the
included studies reported that patient scores on the mediator measures changed between baseline
and post-treatment/follow-up, but only three studies [53,58,59] reported the results of correlation
analyses to show that this change was associated with change in the outcome measure. The fact
that not all studies presented the results of such tests suggests that these criteria were not
adequately assessed.
Another issue, also reported by previous reviews, was the lack of information on the properties of
the measures used. Only Smeets et al. [57] reported information on the measurement properties of
both the potential mediator and the outcome measures. Focht et al. [55] and Wicksell et al. [59] re-
ported characteristics only for their outcome measures and Spinhoven et al. [58] reported character-
istics only for their mediator measures.
In terms of the type of mediation analysis conducted, only two studies [54,59] used an optimal
mediation analysis method as recommended by the above literature (i.e., tested the mediated effect
using non-parametric bootstrapping), and one of these [54] carried out analysis using SEM. No study
reported a power calculation showing that the study was adequately powered to detect mediating
effects. One study included a very small sample [59] and in all cases, the sample used to investigate
mediation relationships was <100. This suggests that the samples may not have been large enough to
adequately perform mediation analysis through the usual methods of multiple regression or SEM and
raises the possibility of Type II errors.
Overall, this review of musculoskeletal treatment mediation reinforces the ﬁndings of system-
atic reviews on other health conditions: few mediation studies have been undertaken, few factors
have been consistently investigated, studies are usually underpowered and methodological quality
is often suboptimal. Collectively, these systematic reviews covering a variety of health conditions
indicate that while there is a pool of applied mediation studies, greater methodological rigour
would help move mediation research forward and potentially provide us with more deﬁnitive
information regarding the factors that explain how treatments work. Despite this, the mediation
literature reports some consistency in the type of psychological factors tested and those found to be
mediators.
To date, very few mediation analyses have been conducted in the ﬁeld of back pain, and only one
[57] appears to have been planned at the time of data collection. We believe that incorporating
mediation analyses into intervention studies presents an excellent opportunity to maximise the yield
of clinical research. Due to the adaptability of the method to different types of studies, including
mediation analyses is likely to require only minor adjustments to study design and conduct. Box 1
summarises the recommendations from the above literature.Box 1 Points to consider when investigating mediation in back pain intervention studies.
 Think about how the interventionmight work, using theory to guide what variables might be
important and how these might lead to change in the outcome
 Ensure the trial is adequately powered to detect mediating effects
 Choose measures for the mediator and outcome variables that have good measurement
properties (i.e., reliable and responsive)
 Ensure the trial is adequately powered to detect mediating effects
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Mediation analysis has the potential to help identify why treatments do or do not work for back
pain. There is clarity about current best practice in mediation study design, analysis and interpretation
that is useful at an individual-study level, and at the condition-speciﬁc level there are theoretical and
methodological frameworks within which mediation analysis studies can be planned, staged and
evaluated. Preplanned and appropriately conducted mediation analysis in adequately powered clinical
trials would be a step forward in understanding treatment effects.
There is emerging evidence about the role of some psychological factors as potential treatment
mediators, such as self-efﬁcacy and catastrophising (see chapter 5), but the evidence is inconsistent
and fewmediation studies have been conducted in back pain. Mediation analysis can also be applied to
non-psychological factors, such as social factors in mediating the relationship between patient-centred
interventions and return to work (see chapter 6 of this issue) and physical factors in mediating the
relationship between exercise and activity limitation.
There is a clear need for further research that investigates plausible mediators. Convincing research
will be based on strong theory and previous evidence, show consistency of ﬁndings across studies and
hopefully demonstrate evidence of dose–response. This evidencewould contribute to greater certainty
about the role of mediators in the treatment of back pain and facilitate the reﬁnement of interventions.
This approach holds promise in disentangling some of the reasons why most back pain treatments
show modest-sized effects and in optimising patient management.Practice Points
 Mediation analysis is useful as it has the potential to help identify why treatments do or do
not work for back pain.
 There is emerging evidence about the role of some psychological factors as treatment me-
diators, such as self-efﬁcacy and catastrophising.
 Few mediation studies have been conducted in back pain-intervention studies.
 Mediation analysis can equally be applied to non-psychological, modiﬁable factors.
Research Agenda
 While there is a pool of applied mediation studies for musculoskeletal pain, greater meth-
odological rigour would help move mediation research forward.
 Treatment-mediation research should ideally: state clear theoretical links between the var-
iables of interest, be preplanned, use adequate measures of constructs, establish temporal
precedence by including measurements during the intervention period, use only appropriate
tests of mediation, be conducted in adequately powered randomised controlled trials and
include models that test multiple mediators reﬂective of the complex nature of the
interventions.
 Randomised controlled trials that incorporate the above-mentioned design aspects are
required to add to the evidence base of those factors already identiﬁed as potential mediators.
There is also scope to test speciﬁc theoretical hypotheses to enhance understanding of the
mechanism of action of intervention regimens for back pain.Conﬂict of interest statement
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